CSTAF
Constellation Acquisition Corp I does not have significant operations. It intends to effect a merger, capital share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.
CSTAF (CSTAF) - Net Assets
Latest net assets as of September 2025: $-21.16 Million USD
Based on the latest financial reports, CSTAF (CSTAF) has net assets worth $-21.16 Million USD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($873.24K) and total liabilities ($22.03 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-21.16 Million |
| % of Total Assets | -2423.34% |
| Annual Growth Rate | 227.8% |
| 5-Year Change | -97.14% |
| 10-Year Change | N/A |
| Growth Volatility | 529152.68 |
CSTAF - Net Assets Trend (2020–2025)
This chart illustrates how CSTAF's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for CSTAF (2020–2025)
The table below shows the annual net assets of CSTAF from 2020 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-09-30 | $8.27 Million | 0.00% |
| 2024-09-30 | $8.27 Million | -74.32% |
| 2023-09-30 | $32.19 Million | -89.34% |
| 2022-09-30 | $302.03 Million | +4.45% |
| 2021-09-30 | $289.16 Million | +1322841.90% |
| 2020-09-30 | $21.86K | -- |
Equity Component Analysis
This analysis shows how different components contribute to CSTAF's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 1985493600.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (September 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $28.12 Million | 340.25% |
| Total Equity | $8.27 Million | 100.00% |
CSTAF Competitors by Market Cap
The table below lists competitors of CSTAF ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
ALL FOR ONE STEEB (A1OS.SG)
STU:A1OS
|
$338.33K |
|
Norvista Capital Corporation
PINK:XTERF
|
$338.66K |
|
NEURONES (NE9.SG)
STU:NE9
|
$338.68K |
|
GS Holdings Corp. Pfd. Series 1
KQ:078935
|
$338.81K |
|
Hire Technologies Inc
OTCQB:HIRRF
|
$338.31K |
|
H&K AG
PA:MLHK
|
$337.93K |
|
FEC Resources Inc
PINK:FECOF
|
$337.77K |
|
MIZUHO FIN GROUP - Dusseldorf Stock Exchang
DU:MZ8
|
$337.62K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in CSTAF's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 8,265,707 to 8,265,707, a change of 0 (0.0%).
- Net loss of 248,000 reduced equity.
- Other factors increased equity by 248,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-248.00K | -3.0% |
| Other Changes | $248.00K | +3.0% |
| Total Change | $- | 0.00% |
Book Value vs Market Value Analysis
This analysis compares CSTAF's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 15.30x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 24268.54x to 15.30x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2020-09-30 | $0.00 | $12.30 | x |
| 2021-09-30 | $7.97 | $12.30 | x |
| 2022-09-30 | $7.79 | $12.30 | x |
| 2023-09-30 | $2.28 | $12.30 | x |
| 2024-09-30 | $0.80 | $12.30 | x |
| 2025-09-30 | $0.80 | $12.30 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently CSTAF utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -3.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 3.41x
- Recent ROE (-3.00%) is below the historical average (-1.97%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2020 | -14.38% | 0.00% | 0.00x | 10.43x | $-5.33K |
| 2021 | 5.44% | 0.00% | 0.00x | 1.07x | $-13.19 Million |
| 2022 | 4.26% | 0.00% | 0.00x | 1.04x | $-17.33 Million |
| 2023 | -1.12% | 0.00% | 0.00x | 1.55x | $-3.58 Million |
| 2024 | -3.00% | 0.00% | 0.00x | 3.41x | $-1.07 Million |
| 2025 | -3.00% | 0.00% | 0.00x | 3.41x | $-1.07 Million |
Industry Comparison
This section compares CSTAF's net assets metrics with peer companies in the Shell Companies industry.
Industry Context
- Industry: Shell Companies
- Average net assets among peers: $36,677,338
- Average return on equity (ROE) among peers: -64.57%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| CSTAF (CSTAF) | $-21.16 Million | -14.38% | N/A | $338.32K |
| Artius II Acquisition Inc. Class A Ordinary Shares (AACB) | $-60.27K | 0.00% | 0.00x | $198.37 Million |
| Artius II Acquisition Inc. Units (AACBU) | $-60.27K | 0.00% | 0.00x | $205.28 Million |
| Ares Acquisition Corporation II (AACT-UN) | $931.34 Million | 0.00% | 0.08x | $399.77 Million |
| AA Mission Acquisition Corp. (AAM-UN) | $-559.90 Million | 0.00% | 0.00x | $349.76 Million |
| Global Acquisitions Corporation (AASP) | $3.80 Million | -5.26% | 0.34x | $15.42 Million |
| ABV Consulting Inc (ABVN) | $8.75K | -623.31% | 2.50x | $461.96K |
| Atlantic Coastal Acquisition Corp II (ACAB) | $-8.52 Million | 0.00% | 0.00x | $2.44 Million |
| Annabidiol Corp (ACBD) | $-501.57K | 0.00% | 0.00x | $13.62K |
| ACRO Biomedical Co Ltd (ACBM) | $685.87K | -17.12% | 0.46x | $30.04K |
| Huaizhong Health Group Inc (ADAD) | $-19.47K | 0.00% | 0.00x | $3.15K |